Transarterial Chemoembolization Plus Radiofrequency Ablation Versus Transarterial Chemoembolization Alone for Intermediate-stage Hepatocellular Carcinoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02435953

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:28:06.332042+00:00

Published At

2026-03-31T00:00:00+00:00

Record Updated At

2026-03-31

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Hepatocellular Carcinoma", "Chemoembolization, Therapeutic", "Ablation Techniques, RFA"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-03-31"

protocolSection.identificationModule.nctId

"NCT02435953"

protocolSection.identificationModule.officialTitle

"Transarterial Chemoembolization Plus Radiofrequency Ablation Versus Transarterial Chemoembolization Alone for Intermediate-stage Hepatocellular Carcinoma"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Hepatocellular Carcinoma (protocolSection.conditionsModule.conditions)
• Chemoembolization, Therapeutic (protocolSection.conditionsModule.conditions)
• Ablation Techniques, RFA (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.